RNAC·816212302·US·equity·Healthcare - Biotechnology-Activist
RNAC (CARTESIAN THERAPEUTICS INC) is held by 47 institutional investors as of Q4 2025. Net institutional sentiment: Mixed.
See how RNAC's score breaks down across 4 SEC sources
This is taking longer than usual. Please try again in a moment.
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer